Generics - GlaxoSmithKline

Filter

Current filters:

GlaxoSmithKline

Popular Filters

1630 to 1639 of 1639 results

Hospira’s first-quarter 2011 results beat forecasts, helped by generic Taxotere

27-04-2011

Specialty drugmaker Hospira (NYSE: HSP) yesterday reported results for the first quarter ended March…

FinancialGenericsHospiraTaxotere

Kaketsuken initiates second trial of flu vaccine using Vivalis EB66 cell line

26-04-2011

Japan’s Chemo-Sero-Therapeutic Research Institute (Kaketsuken) has initiated the first human injection…

GlaxoSmithKlineKaketsukenPharmaceuticalResearchRespiratory and PulmonaryVaccinesVivalis

Alapis enters MoU with China's CSPC Pharma on areas of collaboration

18-04-2011

Greek drugmaker Alapis SA (APSHF: PK) has signed a memorandum of understanding (MoU) with one of China's…

AlapisCSPC PharmaceuticalGenericsLicensing

EMA updates Rxing advice for GlaxoSmithKline’s Pandemrix reflecting possible narcolepsy link

18-04-2011

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended…

EuropeGlaxoSmithKlinePandemrixPharmaceuticalRegulationVaccines

GlaxoSmithKline to shed OTC brands, including Alli, as US consumer group calls for the latter to be banned

18-04-2011

Following up on a previously announced intention, UK pharma giant GlaxoSmithKline (LSE: GSK) says it…

AlliGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalRegulationRocheXenical

1630 to 1639 of 1639 results

Back to top